Effects of sodium hyaluronate and triamcinolone acetonide on proteoglycan metabolism in equine articular chondrocytes treated with interleukin-1

Equine;Chondrocytes;Osteoarthritis;Triamcinolone;Hyaluronic acid

Schaefer, Elysia C. ; Stewart ; Allison A.

关键词: Equine;    Chondrocytes;    Osteoarthritis;    Triamcinolone;    Hyaluronic acid;   

Others  :  https://www.ideals.illinois.edu/bitstream/handle/2142/16488/1_Schaefer_Elysia.pdf?sequence=2&isAllowed=y

美国|英语

来源: The Illinois Digital Environment for Access to Learning and Scholarship

【 摘 要 】

The objective of this study is to determine if the effects of a high molecular weight sodium hyaluronate (HA) alone or in combination with triamcinolone acetate (TA) can mitigate chondrocyte proteoglycan catabolism caused by interleukin-1 (IL-1) administration.Chondrocytes were collected from fetlock joints of ten horses euthanized for reasons unrelated to joint disease.Chondrocyte pellets were treated with media (negative control); media containing IL-1 only (positive control); or media containing IL-1 with HA only (0.5 or 2.0 mg/mL), TA only (0.06 or 0.6 mg/mL), or HA (0.5 or 2.0 mg/mL) and TA (0.06 or 0.6 mg/mL) in combination.Chondrocyte pellets were assayed for newly synthesized GAG, total GAG content, total DNA content, and mRNA levels of collagen type II, aggrecan, and COX-2.The high concentration of HA (2.0 mg/mL) increased GAG synthesis while the high concentration of TA (0.6 mg/mL) decreased loss of GAG into the media.Both the high concentration of HA and TA increased the total GAG content within the pellet.There was no change in pellet DNA content with either treatment.TA reduced COX-2 mRNA levels as well as aggrecan and collagen type II expression.Treatment with HA had no effect on mRNA levels of COX-2, aggrecan or collagen type II.These results indicate that the high concentration of HA or TA alone or in combination will mitigate effects of IL-1 administration on proteoglycan catabolism of equine articular chondrocytes.